← back to search

Georgia R. Lill

Los Angeles Medical Center · US
Area of research
Molecular Biology · Oncology
Research interest
Research interests include CRISPR and Genetic Engineering, CAR-T cell therapy research, Virus-based gene therapy research, and Acute Lymphoblastic Leukemia research.
h-index
7
citations
801
works
17
NIH funding
primary concept
email

Recent publications

Patient characteristics, toxicity, and response after real world administration of obecabtagene autoleucel and brexucabtagene autoleucel for relapsed acute lymphoblastic leukemia: A rocca analysis
Blood 2025cited by 1position: middledoi
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
Cell Reports 2018cited by 140position: middledoi
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Molecular Therapy 2016cited by 215position: middledoi
Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases
Molecular Therapy — Nucleic Acids 2016cited by 56position: middledoi
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Blood 2015cited by 320position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Donald B. Kohn · University of California, Berkeley4 papers (2015–2018)Roger P. Hollis · University of California, Los Angeles4 papers (2015–2018)Aaron Cooper · Memorial Sloan Kettering Cancer Center4 papers (2015–2018)Michael L. Kaufman · University of Colorado Cancer Center3 papers (2015–2018)Megan D. Hoban · Forma Therapeutics (United States)3 papers (2015–2018)Fabrizia Urbinati · Vital Therapies (United States)3 papers (2015–2016)Zulema Romero · University of California, Los Angeles3 papers (2015–2018)Sorel Fitz‐Gibbon · University of California, Los Angeles2 papers (2016–2018)Carmen Flores · Statens Serum Institut2 papers (2016–2016)Beatriz Campo-Fernández · University of California, Los Angeles2 papers (2016–2018)Michelle Mojadidi · AstraZeneca (Brazil)2 papers (2016–2016)Xiaoyan Wang · Qingdao University2 papers (2016–2018)Michelle Ho · National Cancer Institute2 papers (2015–2016)Alok V Joglekar · University of Pittsburgh2 papers (2015–2018)Joseph Long · Flatiron Health (United States)2 papers (2016–2018)Dianne Lumaquin · Tri-Institutional PhD Program in Chemical Biology2 papers (2015–2016) · 1 papers (2015–2015) · 1 papers (2015–2015)Shantha Senadheera · University of California, Los Angeles1 papers (2015–2015) · 1 papers (2015–2015)